Parallax Volatility Advisers
FLXN

Parallax Volatility Advisers’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Parallax Volatility Advisers’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-977
Closed -$18K – 4291
2018
Q3 		$18K Buy
+977
New +$22.4K ﹤0.01% 2163
2018
Q1 		– Sell
-4,998
Closed -$125K – 4825
2017
Q4 		$125K Buy
+4,998
New +$122K ﹤0.01% 2654

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Parallax Volatility Advisers's FLXN Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2018, closing a stake of 977 shares — an estimated $18K sold.

Parallax Volatility Advisers first reported a position in FLXN in Q4 2017 and held it in 2 quarters. The position peaked at $125K in Q4 2017. 125 funds tracked by Wall St. Rank hold FLXN as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining Flexion Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 977 Flexion Therapeutics, Inc. shares in Q4 2018, an estimated $18K.
  • Parallax Volatility Advisers first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Flexion Therapeutics, Inc. position peaked at $125K in Q4 2017.
  • 125 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.